Jan 22 (Reuters) - VALBIOTIS SAS ALVAL.PA :
* VALBIOTIS ANNOUNCES A SIGNIFICANT EFFECT OF VALEDIA ON
INTESTINAL MICROBIOTA
* VALEDIA() ACTS ON MICROBIOTA IMBALANCES ASSOCIATED WITH
METABOLIC DISEASES (PRECLINICAL)
* ADDITIONAL DATA STRENGTHENS VALUE OF VALEDIA FOR
PREVENTING TYPE
2 DIABETES
* VALBIOTIS CONTINUES ITS METAGENOMICS PROGRAM TO ASSESS HOW
ITS
PRODUCTS AFFECT MICROBIOTA
Source text for Eikon: ID:nBw3D2Ssqa
Further company coverage: ALVAL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))